Juvisync Approved for Type 2 Diabetics With High Cholesterol (HealthDay)
HealthDay – FRIDAY, Oct. 7 (HealthDay News) — Juvisync (sitagliptin and
simvastatin) has been approved by the U.S. Food and Drug Administration
for people with type 2 diabetes who also have high cholesterol.